Suri Anish

Suri Anish is listed in filings as PRESIDENT AND CSO at Cue Biopharma, Inc.. This profile follows SEC Form 4 activity through Jun 7, 2024, including 2 public disclosures. Recent filings connect the profile to Cue Biopharma, Inc. (CUE). The current snapshot covers public activity from Mar 8, 2024 to Jun 7, 2024. Reported amounts are shown as $247.5K to $582.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.